Member Info for Ghia

Originally they advertised on the radio in the Southampton area.

They obviously used the latest webinar to request that the journalists promote the home trial.

And they have the 10 NIHR centres that had been engaged on the hospital trial.

There is probably room for improvement on getting the word out but I think the at home trial results are less important for pushing this through approvals.

The process is detailed here:

https://www.covidtrialathome.com/

Essentially if you have symptoms you fill out the questionnaire and if you qualify they set everything in motion, first would be to courier a test to you to verify you actually have Covid.

initially they where looking within a 40mile radius of Southampton but it has been opened up nationally for a while now.

They are targeting 65+ or 55+ in an at risk group.

The slow fill is likely due to the success of the shielding campaign amongst those age groups

There was probably a lot less shares in issue when it was £10, just saying.

But if one of the trials brings it home this share will do well for sure.

Leonard Licht has been a long term investor in SNG he sure does pick good stocks.

Since results where announced he has top sliced twice.

First dropping to 7,770,000

and now reducing to 7,375,000

Just taking a bit of profit off the table, he still holds a considerable ammount

SNG001 has had a preliminary readout already the hospital trial was one arm of the wider study which also includes the at home arm.

Full readouts will not be possible until the at home trials completes then results can be presented as a whole as well as for both arms of the study.

COPD was paused at 109 out of 120 patients they received permission to do an interim readout of the data to support the Covid data.

RM stated COPD will be available in August.

Since COPD is being used to support activities for Covid I expect they already have this data and potential partners and regulatory authorities are also privy under NDA.

If COPD is not announced in August I would suggest this is because one of the above activities is preventing this. Once completed I anticipated news flow to come in one swoop.

Since COPD is an interim readout to support existing trial data I’m unsure as to the rules on when it must be announced to the market.

That would depend on many factors such as the current revenue stream for the company.

Nolupus - How confident are you that the £1.50 support will hold without short term news flow?

I’ve ditched half my holding here with the view to buy back in mid September which will be closer to the stem split.

Lets see if I can get in lower than £1.50

Oil - Not a builder but an enthusiastic DIY’er happily did all the ground working and block paving on my current property.

Considering the age of that property looks fairly new I’d suggest that looks a lot like efflorescence, give it a google it’s common on newly laid paving and fades with time.

Haydn1 - Nice summary I agree entirely.

As others have said it would be out of character for the board to be dropping news left right and centre that adds little value to the journey here.

They will be flat out working hard for the best outcome and when news comes expect it to be accurate, to the point and it should put a smile on everyone’s face.

I think there are many misinformed posters on both boards to be honest.

The concern here would be that IFN IV is not required because inhaled IFN has fixed the problem at source.

Having someone in a hospital bed hooked up to IV costs a significant amount of money, which is why inhaled IFN and Inhaled Remdesivir are favourable IMO plus you can target a higher dose at the lungs without so many side effects.

IV has the benefit of hitting other organs so for late stage infections that could help. Although it is known not to work great with steroids so I’m not sure what happens ref dextamathingy which is now standard of care I believe.

I’m in both but heavily weighted towards SNG

Volat1lity - Sorry couldn’t resist a Sunday evening ramp!

Don’t underestimate the significance of the stem cells info, board played a blinder here dangled the stem carrot With no dates which drove the price up.

Transacted a placing and then gave clearer guidance on stem.

I would be ****ed off if I had bought above £2.

This will rise again in the future but don’t expect to be above £2 until stem split is closer.

Chrishar - You often find companies have habits, Lansdowne TR1’s after 5pm, SNG seem to like 7am RNS’s and with tomorrow being a month on from “Manic Monday” I can’t help but feel a little excited.

I personally never use stop losses, if you look at enough intraday graphs you will see that things rarely go up or down in a straight line.

There will be many examples where a stop loss will have wiped you out only for the share to go on to higher highs. This usually happens very soon after the retrace.

B2HS2L - I don’t profess to know when the US sales if any will drop.

But my view on the 6 monthly’s is that we will finally have an accurate margin figure, current cash position and forward looking statements for the 2nd half of the financial year.

I would have thought sales would be broken down by region too.

If as many believe Primer are sitting on a pile of cash as you allude to there may well be forward looking statements on the plan for the cash M&A activity would be interesting. Perhaps Q2 2021 would be appropriate for an acquisition.

This ones a waiting game.

The virus is still here it’s only likely to get worse leading into winter.

All the hot air from rapid testing companies is still very much hot air.

There are a few PCR suppliers falling by the wayside.

There are a few competitors struggling with the approval times which seem to have extended.

All in all Primer are in a very good position with a product portfolio that is proven and a robust distribution network.

It would be nice to see a few more contracts signed but those that wait until the 6monthly financials should be in for a just reward.

I’m sure they will put a smile on a few peoples faces.

Interesting they offer a market neutral spread betting service so this could be a reflection on their client base which went long earlier in the week and then closed their positions over the weekend.

Not sure I understand what Inter Trader Ltd are up to.

Increasing stake and then decreasing within a matter of days they caught a nice rise that’s for sure.

Does anyone know what they are about?